JP Morgan Chase’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $80.4K | Sell |
|
|||||
|
2025
Q2 | $88K | Buy |
|
|||||
|
2025
Q1 | $58.9K | Sell |
|
|||||
|
2024
Q4 | $267K | Buy |
|
|||||
|
2024
Q3 | $102K | Sell |
|
|||||
|
2024
Q2 | $63.6K | Sell |
|
|||||
|
2024
Q1 | $94.2K | Buy |
|
|||||
|
2023
Q4 | $85K | Sell |
|
|||||
|
2023
Q3 | $105K | Buy |
|
|||||
|
2023
Q2 | $120K | Buy |
|
|||||
|
2023
Q1 | $96K | Buy |
|
|||||
|
2022
Q4 | $73K | Buy |
|
|||||
|
2022
Q3 | $94K | Buy |
|
|||||
|
2022
Q2 | $146K | Buy |
|
|||||
|
2022
Q1 | $140K | Buy |
|
|||||
|
2021
Q4 | $172K | Sell |
|
|||||
|
2021
Q3 | $163K | Sell |
|
|||||
|
2021
Q2 | $280K | Buy |
|
|||||
|
2021
Q1 | $264K | Buy |
|
|||||
|
2020
Q4 | $399K | Buy |
|